Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-04-23 @ 9:57 PM
Study NCT ID:
NCT02832102
Status:
UNKNOWN
Last Update Posted:
2016-07-14
First Post:
2016-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)
Sponsor:
Azienda Ospedaliero-Universitaria di Parma
Organization:
Study Overview
Official Title:
Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)
Status:
UNKNOWN
Status Verified Date:
2016-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BD2Decide
Brief Summary:
The purpose of this study is to determine new multiscale signatures for the prediction of head and neck cancer (HNC) patients disease outcome, in particular for advanced stage (stage III, IV) human papillomavirus (HPV) negative patients and to validate prognostic models for overall survival.
Detailed Description:
The clinical study is devoted to the validation of a decision support system for HNC patients management in the frame of a H2020 project.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: